Topic 12 消化器疾患の栄養管理

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.11244/JJSPEN.28.699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• An Evidence‐Based Systematic Review on the Management of Irritable Bowel Syndrome

  2009cited by this paper
• Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

  2008cited by this paper
• Effect of the ingestion of a symbiotic yogurt on the bowel habits of women with functional constipation.

  2008cited by this paper
• Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence.

  2008cited by this paper
• Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas

  2008cited by this paper
• Diverticular Disease and Diverticulitis

  2008cited by this paper
• Gastrointestinal Microbiota in Irritable Bowel Syndrome: Their Role in Its Pathogenesis and Treatment

  2008cited by this paper
• Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials.

  2008cited by this paper
• The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

  2008cited by this paper
• Systematic Management of Postoperative Enterocutaneous Fistulas: Factors Related to Outcomes

  2008cited by this paper
• The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders

  2008cited by this paper
• Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.

  2007cited by this paper
• Nutrition assessment of patients with inflammatory bowel disease.

  2007cited by this paper
• The significance of bowel permeability

  2007cited by this paper
• Review article: lactose intolerance in clinical practice – myths and realities

  2007cited by this paper
• Fermented cereal with specific bifidobacteria normalizes bowel movements in elderly nursing home residents. A randomized, controlled trial.

  2007cited by this paper
• First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications.

  2007cited by this paper
• Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.

  2007cited by this paper
• Inflammatory bowel disease: cause and immunobiology

  2007cited by this paper
• Prebiotics, probiotics, and dietary fiber in gastrointestinal disease.

  2007cited by this paper
• Current status of transplantation of the small intestine.

  2007cited by this paper
• Inflammatory bowel disease: clinical aspects and established and evolving therapies

  2007cited by this paper
• Perceived food intolerance in subjects with irritable bowel syndrome – etiology, prevalence and consequences

  2006cited by this paper
• Review article: uncomplicated diverticular disease of the colon

  2006cited by this paper
• Intestinal failure-associated liver disease: what do we know today?

  2006cited by this paper
• Mesalazine and/or Lactobacillus casei in Preventing Recurrence of Symptomatic Uncomplicated Diverticular Disease of the Colon: A Prospective, Randomized, Open-label Study

  2006cited by this paper
• Nutritional care of the patient with constipation.

  2006cited by this paper
• Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis

  2006cited by this paper
• ESPEN Guidelines on Enteral Nutrition: Gastroenterology.

  2006cited by this paper
• Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment.

  2006cited by this paper
• Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review

  2006cited by this paper
• Survival and dependence on home parenteral nutrition: experience over a 25‐year period in a UK referral centre

  2006cited by this paper
• Short bowel syndrome and intestinal failure: consensus definitions and overview.

  2006cited by this paper
• The role of fiber in the treatment of irritable bowel syndrome: therapeutic recommendations.

  2006cited by this paper
• Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management.

  2006cited by this paper
• Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.

  2006cited by this paper
• Review of data of the patients receiving total parenteral nutrition at the intensive care unit of a university hospital.

  2006cited by this paper
• Nutrition and management of enterocutaneous fistula

  2006cited by this paper
• Current management of enterocutaneous fistula

  2006cited by this paper
• T cell activation altersintestinal structure and function

  2006cited by this paper
• Orthotopic transplantation of intestinal mucosal organoids in rodents.

  2006cited by this paper
• Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level.

  2005cited by this paper
• Food-Specific Serum IgG4 and IgE Titers to Common Food Antigens in Irritable Bowel Syndrome

  2005cited by this paper
• Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.

  2005cited by this paper
• Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial.

  2005cited by this paper
• Myths and Misconceptions About Chronic Constipation

  2005cited by this paper
• The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.

  2005cited by this paper
• Protein kinetic differences between children with edematous and nonedematous severe childhood undernutrition in the fed and postabsorptive states.

  2005cited by this paper
• Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease.

  2005cited by this paper
• An Evidence-Based Approach to the Management of Chronic Constipation in North America

  2005cited by this paper
• Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth

  2005cited by this paper
• Maintenance therapy with a probiotic in antibiotic‐dependent pouchitis: experience in clinical practice

  2005cited by this paper
• Meta‐analysis: the treatment of irritable bowel syndrome

  2004cited by this paper
• Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

  2004cited by this paper
• Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula

  2004cited by this paper
• IBD: a family affair.

  2004cited by this paper
• Enteral Administration of High-Fat Nutrition Before and Directly After Hemorrhagic Shock Reduces Endotoxemia and Bacterial Translocation

  2004cited by this paper
• The Pathology of Diverticulosis Coli

  2004cited by this paper
• An 11‐year experience of enterocutaneous fistula

  2004cited by this paper
• Pretreatment With High-Fat Enteral Nutrition Reduces Endotoxin and Tumor Necrosis Factor-&agr; and Preserves Gut Barrier Function Early After Hemorrhagic Shock

  2004cited by this paper
• Clinical Outcome and Factors Predictive of Recurrence After Enterocutaneous Fistula Surgery

  2004cited by this paper
• Detoxification of Lithocholic Acid, A Toxic Bile Acid: Relevance to Drug Hepatotoxicity

  2004cited by this paper
• Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost‐effectiveness analysis

  2004cited by this paper
• Self-reported milk intolerance in irritable bowel syndrome: what should we believe?

  2004cited by this paper
• Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

  2004cited by this paper
• Review article: the role of nutrition in the treatment of inflammatory bowel disease.

  2004cited by this paper
• Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis.

  2004cited by this paper
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• New and Emerging Therapies for Short Bowel Syndrome in Children

  2004cited by this paper
• The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon

  2003cited by this paper
• Butyrate‐treated colonic Caco‐2 cells exhibit defective integrin‐mediated signaling together with increased apoptosis and differentiation

  2003cited by this paper
• Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure

  2003cited by this paper
• The medical management of intestinal failure: methods to reduce the severity

  2003cited by this paper
• Diet and Functional Gastrointestinal Disorders: A Population-Based Case—Control Study

  2003cited by this paper
• Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation.

  2003cited by this paper
• Current concepts: Chronic constipation

  2003cited by this paper
• Butyrate downregulates α2β1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines

  2003cited by this paper
• Coeliac disease presenting with symptoms of irritable bowel syndrome

  2003cited by this paper
• Small Bowel Bacterial Overgrowth, Celiac Disease, and IBS: What Are the Real Associations?

  2003cited by this paper
• Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness

  2003cited by this paper
• Management of enterocutaneous fistulas: 30-year clinical experience.

  2003cited by this paper
• Surgical management of intestinal failure

  2003cited by this paper
• AGA technical review on irritable bowel syndrome.

  2002cited by this paper
• Immunoregulation in the gut: success and failures in human disease

  2002cited by this paper
• Mucosal flora in inflammatory bowel disease.

  2002cited by this paper
• Prevention of parenteral nutrition‐associated liver disease in children

  2002cited by this paper
• Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas.

  2002cited by this paper
• American Gastroenterological Association medical position statement: irritable bowel syndrome.

  2002cited by this paper
• Glutamine supplementation in serious illness: A systematic review of the evidence*

  2002cited by this paper
• Irritable bowel syndrome: a little understood organic bowel disease?

  2002cited by this paper
• Evolving pathophysiologic models of functional gastrointestinal disorders.

  2002cited by this paper
• Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients With an Ileal Pouch-Anal Anastomosis

  2002cited by this paper
• Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial

  2002cited by this paper
• Bifidobacterium animalis strain DN‐173 010 shortens the colonic transit time in healthy women: a double‐blind, randomized, controlled study

  2002cited by this paper
• Research approaches for pre- and probiotics: challenges and outlook

  2002cited by this paper
• Immunopathogenesis of inflammatory bowel disease

  2002cited by this paper
• Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care.

  2001cited by this paper
• Modulation of colonic barrier function by the composition of the commensal flora in the rat

  2001cited by this paper
• Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome.

  2001cited by this paper
• AGA technical review on the evaluation of food allergy in gastrointestinal disorders

  2001cited by this paper

• No citing papers are available for this paper.